Keith Schmidt - Net Worth and Insider Trading
Keith Schmidt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Keith Schmidt owns 2 companies in total, including Avalo Therapeutics Inc (AVTX) , and Plug Power Inc (PLUG) .
Click here to see the complete history of Keith Schmidt’s form 4 insider trades.
Insider Ownership Summary of Keith Schmidt
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVTX | Avalo Therapeutics Inc | 2019-06-11 | director |
| PLUG | Plug Power Inc | 2022-08-19 | GM New Mkts & Pres New Prd Dv |
Keith Schmidt Trading Performance
Keith Schmidt Ownership Network
Keith Schmidt Owned Company Details
What does Avalo Therapeutics Inc do?
Who are the key executives at Avalo Therapeutics Inc?
Keith Schmidt is the director of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include director & 10 percent owner Armistice Capital Master Fund Ltd. , 10 percent owner Caissa Capital Management Ltd. , and Interim CFO Christopher Ryan Sullivan .
Avalo Therapeutics Inc (AVTX) Insider Trades Summary
Over the past 18 months, Keith Schmidt made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net purchase of 34,840 shares made by Caissa Capital Management Ltd. , a net sale of 3,683,542 shares made by Armistice Capital Master Fund Ltd. , and a net purchase of 4,000 shares made by Garry Arthur Neil .
In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc (AVTX) in total and bought 1,000 shares, with a net purchase of 1,000 shares. During the past 18 months, 15,348 shares of Avalo Therapeutics Inc (AVTX) were sold and 1,164 shares were bought by its insiders, resulting in a net sale of 14,184 shares.
Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avalo Therapeutics Inc Insider Transactions
Keith Schmidt Mailing Address
Above is the net worth, insider trading, and ownership report for Keith Schmidt. You might contact Keith Schmidt via mailing address: C/o Chelsea Therapeutics, Inc., 13950 Ballantyne Corporate Pl, Unit 325, Charlotte Nc 28277.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
